MYELOPROLIFERATIVE NEOPLASM (MDS/MPN)

Clinical trials for MYELOPROLIFERATIVE NEOPLASM (MDS/MPN) explained in plain language.

Never miss a new study

Get alerted when new MYELOPROLIFERATIVE NEOPLASM (MDS/MPN) trials appear

Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM (MDS/MPN), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Terminated 1

Experimental drug ADCT-301 tested in just 3 patients for relapsed blood cancers

Disease control Terminated

This study tested a drug called ADCT-301 in 3 adults whose acute myeloid leukemia, myelodysplastic syndrome, or related blood cancer came back after a stem cell transplant. The goal was to see if the drug is safe and can help patients achieve remission. The study was stopped earl…

Matched conditions: MYELOPROLIFERATIVE NEOPLASM (MDS/MPN)

Phase: PHASE2 • Sponsor: Gwynn Long, M.D. • Aim: Disease control

Last updated May 17, 2026 09:08 UTC

MYELOPROLIFERATIVE NEOPLASM (MDS/MPN)

Get alerted when new MYELOPROLIFERATIVE NEOPLASM (MDS/MPN) trials appear

Experimental drug ADCT-301 tested in just 3 patients for relapsed blood cancers